Teva-Allergan deal a booster for Indian companies - The Economic Times
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva buys Allergan's generic drug unit for $40.5B
Allergan steps away from generics with sale to Teva | Business | Chemistry World
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Teva acquires Allergan's generics operations in $38.8bn deal - PMLiVE
Dr Reddy's in $350 million deal to buy 8 US drugs from Teva, Allergan - Times of India
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva's deal with Allergan continues a massive year for pharma M&A — Quartz
Teva Springs for $40.5B Allergan Generics Acquisition Instead of Mylan Bid - YouTube
Teva buys Anda for $500 million - ISRAEL21c
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Mayne vaults ahead in U.S. with $652M deal for Teva/Allergan meds | Fierce Pharma
Teva Allergan Merger
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Allergan Generics acquired by Teva in $40.5bn deal — Financier Worldwide
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Teva wants Allergan's distribution biz now that $40B drug deal has closed | Fierce Pharma
Teva investors fret over $41bn generic drugs deal | Financial Times
Teva Pharmaceuticals Announces $40.5 Billion Deal For Allergan's Generic Drug Unit
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
